What is the optimal testing strategy for oropharyngeal Neisseria gonorrhoeae in men who have sex with men? Comparing selective testing versus routine universal testing from Dutch STI clinic data (2008-2017).
The majority of oropharyngeal Neisseria gonorrhoeae infections are asymptomatic, and many infections remain undetected, creating a reservoir for ongoing transmission and potential drug resistance. It is unclear what the optimal testing policy is in men who have sex with men (MSM), as routine universal testing data are lacking. Surveillance data from all Dutch STI clinics between 2008-2017 were used (n=271,242 consultations). Oropharyngeal testing policy was defined as routine universal testing when ≥85% of consultations included oropharyngeal testing, or as selective testing(<85% tested). Independent risk factors for oropharyngeal Neisseria gonorrhoeae were assessed among MSM routinely universally screened using backward multivariable logistic regression analyses. Routine universal testing was performed in 90%(238,619/265,127) of consultations. Prevalence was higher using routine universal testing (5.5%,95%CI5.4-5.6, 12,769/233,476) compared to selective testing (4.7%,95% CI4.4-5.0,n=799/17,079,P<0.001). The proportion of oropharyngeal-only infections was 55% and 47% respectively. Independent risk factors were age <31 years (OR2.1,95%CI1.9-2.3) age 31-43 years (OR1.7,95%CI1.6-1.9, compared to >43years), being notified for any STI (OR2.0,95%CI1.9-2.1), concurrent urogenital N.gonorrhoeae (OR2.4,95%CI2.1-2.7), and concurrent anorectal N.gonorrhoeae (OR11.4,95%CI10.6-12.3). When using any of the risk factors age, notified or oral sex as testing indicators, 98.4%(81,022/82,332) of MSM would be tested, finding 99.5%(4,814/4,838) of infections. Routine universal testing detected more oropharyngeal N.gonorrhoeae infections compared to selective testing, of which more than half would be oropharyngeal-only. Using independent risk factors as testing indicator is not specific. Therefore, routine universal oropharyngeal testing in MSM is feasible and warranted, as is currently advised in most guidelines.